MedPath

Characteristics and Prognostic Outcomes of Diaphragmatic Ultrasound in Myasthenia Gravis

Active, not recruiting
Conditions
Myasthaenia Gravis
Registration Number
NCT06707727
Lead Sponsor
First Affiliated Hospital of Chongqing Medical University
Brief Summary

The goal of this observational study is to learn about the characteristics and prognostic outcomes of diaphragmatic ultrasound in myasthenia gravis. The main question it aims to answer is:

Does diaphragmatic ultrasound predict prognosis of myasthenia gravis in six months? Participants diagnosed as myasthenia gravis will take the diaphragm ultrasound examinations.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • 1: Patients who seek treatment at the First Affiliated Hospital of Chongqing Medical University and have fluctuating skeletal muscle weakness and at least one of the following three conditions will be included: positive reaction to cholinesterase inhibitors

    2: Serum positive antibodies against acetylcholine receptors, muscle specific kinases, or lipoprotein related proteins

    3: Repeated electrical stimulation examination showed a decrease in wave amplitude.

Exclusion Criteria
  • 1: Patients with lung disease or heart failure, or a history of non-invasive ventilator or tracheotomy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
QMG changes6 months
Secondary Outcome Measures
NameTimeMethod
Changes in medication type or dose6 months

acetylcholinesterase inhibitors, glucocorticoid, immunosuppressant

respiratory infection6 months

Trial Locations

Locations (1)

The First Affiliated Hospital of Chongqing Medical University

🇨🇳

Chongqing, Chongqing, China

© Copyright 2025. All Rights Reserved by MedPath